- Home
- BTSG vs LGND Comparison
BTSG vs LGND Comparison
Compare BTSG & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTSG
- LGND
- Stock Information
- Founded
- BTSG 1974
- LGND 1987
- Country
- BTSG United States
- LGND United States
- Employees
- BTSG N/A
- LGND N/A
- Industry
- BTSG
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- BTSG
- LGND Health Care
- Exchange
- BTSG NYSE
- LGND Nasdaq
- Market Cap
- BTSG 2.0B
- LGND 2.3B
- IPO Year
- BTSG 2024
- LGND 1992
- Fundamental
- Price
- BTSG $20.89
- LGND $117.36
- Analyst Decision
- BTSG Strong Buy
- LGND Strong Buy
- Analyst Count
- BTSG 13
- LGND 6
- Target Price
- BTSG $18.88
- LGND $145.00
- AVG Volume (30 Days)
- BTSG 954.2K
- LGND 119.5K
- Earning Date
- BTSG 02-02-2025
- LGND 02-25-2025
- Dividend Yield
- BTSG N/A
- LGND N/A
- EPS Growth
- BTSG N/A
- LGND 160.46
- EPS
- BTSG N/A
- LGND 2.47
- Revenue
- BTSG $10,588,215,000.00
- LGND $152,422,000.00
- Revenue This Year
- BTSG $29.14
- LGND $26.86
- Revenue Next Year
- BTSG $10.84
- LGND $14.95
- P/E Ratio
- BTSG N/A
- LGND $45.27
- Revenue Growth
- BTSG 25.72
- LGND N/A
- 52 Week Low
- BTSG $7.85
- LGND $67.72
- 52 Week High
- BTSG $21.34
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- BTSG 76.39
- LGND 58.49
- Support Level
- BTSG $17.37
- LGND $102.79
- Resistance Level
- BTSG $17.63
- LGND $112.61
- Average True Range (ATR)
- BTSG 1.05
- LGND 4.02
- MACD
- BTSG 0.33
- LGND 0.87
- Stochastic Oscillator
- BTSG 92.60
- LGND 98.85
About BTSG BRIGHTSPRING HEALTH SERVICES INC
BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Service. and others. It generates the majority of its revenue from the Pharmacy Solutions segment.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.